Supplements to increase milk supply are a multi-million-dollar category, and most of the products in it rest on weaker evidence than their marketing suggests. The single intervention with the strongest research behind it is not a capsule or a tea. It is frequent, effective milk removal by a well-latched baby or a properly-fitted pump, supported by skin-to-skin contact. Galactagogues, the umbrella term for substances purported to boost lactation, are at best an adjunct to that mechanical foundation [abm_protocol9] [foong2020].
This article walks through what the trials actually show for the most-searched supplements to increase milk supply — fenugreek, moringa, blessed thistle, shatavari, oats, brewer's yeast, and the prescription pharmaceutical domperidone. It also covers the harder question most lactation-supplement articles dodge: what you should not take while nursing, including weight-loss supplements and certain herbal extracts. The goal is not to talk you out of trying anything. It is to give you the same honest read a thoughtful IBCLC and physician would.
Before you start anything: Consult a lactation consultant (IBCLC — International Board Certified Lactation Consultant) and your physician before starting any galactagogue. Most cases of perceived low supply are best addressed by feeding frequency, latch correction, and ruling out an underlying medical cause — not by a supplement.
This article is for informational purposes only and is not medical advice. Speak with a qualified healthcare provider, including a lactation consultant (IBCLC) and your physician, before starting any supplement during pregnancy or breastfeeding.
What galactagogues are: the supplements to increase milk supply, in context
A galactagogue (sometimes spelled galactogogue) is any substance, herbal or pharmaceutical, used to induce, maintain, or increase milk production. The Academy of Breastfeeding Medicine's Clinical Protocol #9, the most widely-cited clinical reference on the topic, defines galactagogues as agents to consider after non-pharmacological measures have proven insufficient [abm_protocol9]. The protocol's order of operations matters when you are evaluating supplements to increase milk supply: removal first, supplements second.
How human lactation actually works
Two hormones drive lactation. Prolactin from the anterior pituitary signals milk synthesis. Oxytocin from the posterior pituitary triggers the let-down reflex that ejects milk through the ducts. Postpartum prolactin runs high in the first weeks and then settles. What carries supply forward after that is a local control system in the breast itself: a substance called Feedback Inhibitor of Lactation (FIL) accumulates in alveoli that have not been emptied, and it down-regulates synthesis in that breast. So how often and how completely milk gets removed is the primary driver of how much milk gets made. Frequent, effective removal signals the system to keep producing. Incomplete drainage signals it to slow down.
Why supplements are adjunct, not the foundation
This is the line most lactation-supplement articles bury at the end. The 2020 Cochrane systematic review by Foong and colleagues pooled trials of oral galactagogues across both natural therapies and pharmaceuticals, and concluded the evidence base is too low-quality to support routine recommendation for any of them [foong2020]. ABM Protocol #9 places non-pharmacological intervention first: frequent feeds (8–12 per 24 hours in the early weeks), skin-to-skin contact, optimised latch, and IBCLC support to identify mechanical or anatomical problems that no supplement can fix [abm_protocol9].
This does not mean galactagogues are useless. It means they are most useful on top of a good mechanical foundation, in mothers with a specific clinical need (preterm infant, pump-dependence, relactation), and ideally under guidance. A supplement that adds a small bump to milk volume in a mother who is also feeding ten times a day and being supported by an IBCLC is a different outcome than the same supplement taken alone while the underlying drainage problem goes unaddressed.
Fenugreek for breastfeeding — what the trials actually show
Fenugreek (Trigonella foenum-graecum) is the most-searched lactation supplement on the internet and the one most commonly found in lactation-tea blends. It is a legume in the Fabaceae family, and the seeds have been used in South Asian and Middle Eastern cooking and traditional medicine for centuries. The active components most often invoked are 4-hydroxyisoleucine, trigonelline, diosgenin, and several saponins. The honest mechanistic answer is that we do not know how, or whether, it increases milk supply in humans. Proposed pathways include phytoestrogenic activity and sweat-gland-mediated effects (the mammary gland is, in evolutionary terms, a modified sweat gland), but none of them has been pinned down in human clinical work.
Does fenugreek really work?
The trial data is mixed and small. A 2018 network meta-analysis by Khan and colleagues compared galactagogues across studies and found fenugreek to be statistically associated with increased milk volume, while the underlying trials were small and methodologically uneven [khan2017]. A 2018 randomised double-blind trial by Bumrungpert and colleagues in Thai mothers reported about a 49% increase in milk volume at four weeks using a fenugreek-ginger-turmeric blend versus placebo [bumrungpert2018]. Pulling in the opposite direction: the 2018 herbal-galactagogue systematic review by Bazzano and colleagues rated the fenugreek evidence as low-quality, citing small samples, heterogeneous outcomes, and high risk of bias [bazzano2018]. The Cochrane review reached the same conclusion across the broader galactagogue literature [foong2020]. The InfantRisk Center at Texas Tech notes that recent reviews fail to find consistent benefit and rates the studies as low quality.
Hale's Medications and Mothers' Milk, the standard pharmacological reference for lactation, lists fenugreek as Lactation Risk Category L3, meaning limited data with probable compatibility, with explicit cautions for several populations covered below [hale_lactrisk]. Where this leaves a mother weighing the question: fenugreek may help some women, with a 24–72-hour onset window for those who respond. Whether you are a responder is something only a trial period will tell you. Expect modest, not dramatic, effects, and stack the supplement on top of frequent effective milk removal, not in place of it.
Fenugreek dose if you try it
The doses used in studies and traditional practice cluster around 1,800–6,000 mg of fenugreek seed per day, divided into three doses with meals. Capsules are typically 580–610 mg, so the higher end works out to about three or four capsules three times daily. Tea preparations deliver less per serving and tend to be weaker. One practical signal that you are absorbing fenugreek systemically is a faint maple-syrup or burnt-sugar smell that emerges in sweat and urine within a few days. The smell itself is harmless. It does matter clinically, for the reasons below.
Fenugreek safety — the contraindications that matter
This is where the article gets specific. The following are documented in the pharmacology literature, in LactMed, on NIH MedlinePlus, and in case reports — they are not theoretical. If any of these applies to you, fenugreek is either contraindicated or warrants explicit medical supervision:
- Diabetes (Type 1 or Type 2). Fenugreek has a real hypoglycaemic effect; the 4-hydroxyisoleucine component is studied as an insulinotropic agent. In a mother on insulin or sulfonylureas, fenugreek can precipitate low blood sugar. Both MedlinePlus and LactMed flag this [medlineplus_fenugreek] [lactmed_fenugreek].
- Asthma. Fenugreek is in the legume family, and bronchospasm has been reported in atopic individuals exposed orally or topically. The mechanism overlaps with the legume cross-reactivity described next [patil1997_fenugreek_anaphylaxis].
- Chickpea, peanut, soybean, or lentil allergy. Fenugreek shares allergenic proteins with the Fabaceae family. Documented anaphylaxis case reports exist in peanut-allergic individuals exposed to fenugreek. This is the contraindication most often missed in lay-press lactation-supplement coverage [patil1997_fenugreek_anaphylaxis].
- Anticoagulant or antiplatelet use. Fenugreek contains coumarin-like compounds, and INR elevation has been reported in warfarin users. Heparin, DOACs, aspirin, and clopidogrel all warrant caution [medlineplus_fenugreek].
- Maple-syrup smell in mother and infant. Sotolone is excreted in sweat, urine, and breast milk during fenugreek use, producing a maple-syrup or burnt-sugar body odor that has appeared in case reports in both mother and breastfed infant. The clinical concern is not the smell itself. It is that newborn screening for maple syrup urine disease (MSUD) can be confounded by it. If you start fenugreek, tell your paediatrician so the smell is not misread on a neonatal evaluation [lactmed_fenugreek].
- Pregnancy. Fenugreek shows uterine-stimulant activity in animal studies and is contraindicated during pregnancy. Use in lactation is a separate question, but it is not a supplement to start in the third trimester anticipating breastfeeding.
Common, mild side effects (in mothers without the contraindications above) are GI: bloating, diarrhea, loose stools, and the maple-syrup smell. There are isolated reports of loose stools in breastfed infants. These resolve when fenugreek is stopped.
Moringa — the best-evidence herbal galactagogue
Moringa (Moringa oleifera) is a tree native to South Asia whose leaves are eaten as a vegetable and dried/powdered for supplementation. It is nutritionally dense — protein, iron, calcium, vitamin A, and several flavonoids and polyphenols. In the lactation literature it goes by the local Philippine name malunggay, which is how the strongest trial data is indexed.
Moringa evidence
Two Philippine RCTs are the backbone of the moringa-as-galactagogue case. Estrella and colleagues in 2000 randomised 68 mothers of preterm infants to malunggay 250 mg twice daily or placebo. Pumped milk volumes were higher in the moringa group from postpartum day 3 onward, with day-4 and day-5 volumes roughly doubling versus placebo [estrella2000]. A 2005 trial by Espinosa-Kuo with a similar design and sample size (also n=68, preterm-infant mothers) replicated the milk-volume increase [espinosa_kuo2005]. A 2014 review and a later 2020 systematic synthesis both concluded that moringa showed the most consistent direction of effect among studied herbal galactagogues. They also noted that the trials were small and conducted in populations with marginal nutritional status, so the benefit may be partly nutritional (correcting iron and protein insufficiency) rather than a pure pharmacological galactagogue effect [raguindin2020].
That nuance matters for a well-nourished Western mother. The effect size you might expect could be smaller than the Philippine trials suggest, because part of the signal in those studies was correcting a nutritional deficit you might not have. It also matters because moringa is the herbal option with the most plausible biological rationale, in addition to whatever direct prolactin effect it has via proposed dopamine antagonism in animal data.
Moringa dose and safety
Studied doses range from 250 mg twice daily (the Estrella protocol) up to about 1 g per day of standardised leaf extract, or 1–2 g per day of leaf powder. LactMed considers moringa compatible with breastfeeding at studied doses and notes no adverse effects in mother or infant in clinical trials [lactmed_moringa]. Two caveats apply:
- Oxalate content. Moringa leaves contain roughly 430 mg oxalate per 100 g of dry leaf. This is relevant for mothers with a history of calcium oxalate kidney stones. Moderate intermittent use is unlikely to be a problem; chronic high doses warrant discussion with a clinician.
- Avoid root and bark preparations during pregnancy. Traditional medicine has used moringa root and bark as an abortifacient. The leaf is what the lactation trials studied, and that is what the marketed supplements deliver. Make sure your product is leaf-based.
A theoretical goitrogenic effect from low-level glucosinolates in moringa leaves has been raised, but clinical relevance at typical doses appears minimal. Mothers with pre-existing thyroid disease should flag the supplement to their endocrinologist regardless.
Other herbal galactagogues — honest evidence levels
The remaining options in this category are commonly marketed but thinly studied. Treating each at proper length would not change the conclusion, so the summaries below are brief on purpose.
Blessed thistle
Blessed thistle (Cnicus benedictus) appears in nearly every lactation-tea blend, almost always combined with fenugreek. There is no robust isolated trial of blessed thistle for milk supply; its evidence base is entangled with the fenugreek studies it is co-administered with. Treat it as a traditional add-on of unknown independent effect. Mothers with ragweed or daisy-family allergy should avoid it.
Shatavari
Shatavari (Asparagus racemosus), an Ayurvedic herb with phytoestrogenic saponins, has one small trial by Gupta and Shaw (2011) reporting increased prolactin and milk volume, but the methodology has been criticised in subsequent reviews [bazzano2018]. The honest read is "very weak evidence; insufficient to recommend or rule out". Phytoestrogen content makes it a theoretical concern in mothers with estrogen-sensitive cancers.
Oats and oatmeal
Oats are the most-cited folk lactation food in North America. There is zero randomised-controlled trial evidence for milk-volume effects. The proposed mechanism (beta-glucan modulating prolactin) is animal-model speculation. Oatmeal is a nutritionally reasonable postpartum food on its own merits — it is just not a proven galactagogue. Mothers with celiac disease should choose certified gluten-free oats to avoid cross-contamination.
Brewer's yeast
Brewer's yeast (Saccharomyces cerevisiae), the by-product of beer brewing, is rich in B-vitamins, chromium, and selenium. No RCT has tested it for milk supply. Where mothers are B-vitamin deficient, repletion could plausibly contribute indirectly. The bitter taste limits compliance. It can interact with MAOI antidepressants because of tyramine content and is not appropriate in inflammatory bowel disease.
Lactation teas and lactation cookies
These products generally combine fenugreek, blessed thistle, fennel, and anise at doses well below what would be considered therapeutic. Whatever effect they have is some combination of placebo, ritual, hydration prompt, and (for cookies) the calorie load. They are not unsafe at usual consumption for most mothers; they are just unlikely to do much pharmacologically. If they give you a sense of agency over the situation and you tolerate them, there is no reason to actively avoid them. If you are paying premium prices expecting a measurable supply increase, you are likely overpaying for a small effect.
Domperidone — the prescription pharmacological option
Domperidone deserves a separate, clearly-flagged section because it is the only galactagogue with reasonably solid evidence behind it. It is also the only one with a serious safety profile.
Domperidone is a peripheral dopamine D2 receptor antagonist used in the EU, UK, Australia, and Canada primarily for gastrointestinal motility, and off-label as a lactation aid. By blocking dopamine's tonic inhibition of pituitary prolactin secretion, it raises serum prolactin and, in most responders, milk volume. A 2018 systematic review and meta-analysis by Grzeskowiak and colleagues pooled the RCT evidence and reported a milk-volume increase of about 85 mL per day versus placebo (95% CI 36–133 mL/day) [grzeskowiak2018]. The earlier Wan 2008 RCT in mothers of preterm infants showed the same direction at a domperidone dose of 10 mg three times daily for 14 days [wan2008]. Transfer into breast milk is minimal, with a relative infant dose around 0.012%. Exposure to the nursling at standard maternal doses is considered negligible.
Important caveats — read carefully:
- Not FDA-approved in the United States. The FDA issued a 2004 warning specifically against using domperidone for milk production, citing the risk of cardiac arrhythmia (including QT-interval prolongation) and reports of sudden death with high-dose IV use [fda_domperidone_2004]. US mothers sometimes obtain it through personal-use importation; that is a regulatory grey zone, not a clearance.
- Available by prescription in the EU, UK, Australia, and Canada for GI use, and off-label for lactation. Health Canada in 2012 advised limiting doses to ≤30 mg/day in response to the QT-prolongation signal.
- Contraindicated in mothers with prolonged QT, electrolyte abnormalities (low potassium, low magnesium), or concurrent QT-prolonging medications (including ondansetron, fluconazole, citalopram, methadone, and some macrolide antibiotics). CYP3A4 inhibitors such as ketoconazole, erythromycin, and grapefruit substantially raise plasma domperidone levels.
- Requires physician evaluation. Some clinical protocols include a baseline ECG and electrolyte check.
This article describes domperidone factually because it is what the evidence base shows and because mothers will encounter it in any informed search. It is not a recommendation. The decision to use domperidone for lactation belongs with a physician who knows your cardiac and medication context, not with a search engine.
Supplements to avoid while breastfeeding — the defensive list
This section is the one most lactation-supplement articles skip. The biggest harm-reduction value here is not adding another galactagogue to your shopping cart. It is making sure nothing in that cart actively works against you or your infant.
Do not use weight-loss supplements, fat burners, appetite suppressants, or stimulant-based "energy" blends while breastfeeding. These are not galactagogues, and several have documented infant safety concerns. The same applies to most herbal slimming teas.
Why not fat burners
Most products marketed for postpartum weight loss combine some subset of caffeine concentrate, yohimbine, synephrine (bitter orange), green tea extract dosed for catechin yield, conjugated linoleic acid (CLA), and garcinia cambogia. Each carries lactation-specific concerns:
- Yohimbine is a sympathomimetic alpha-2 antagonist with cardiovascular effects in the mother. LactMed advises avoidance during breastfeeding [lactmed_yohimbine]. Synephrine (bitter orange) carries similar sympathomimetic risks. High-dose caffeine concentrates transfer into milk and have been associated with infant irritability and poor sleep at maternal intakes well above the 200–300 mg/day generally considered acceptable.
- Green tea extract dosed for EGCG is not the same as drinking a cup of green tea. EFSA's 2018 scientific opinion flagged hepatotoxicity concerns at intakes of approximately 800 mg EGCG per day from supplements [efsa_egcg2018]. Concentrated catechin supplements should be avoided in lactation.
- CLA has been shown to reduce milk fat content in dairy cattle. This is a well-replicated animal finding; it has not been directly demonstrated in humans, but it is a sufficient reason for caution given that milk fat carries calories your infant needs.
- Garcinia cambogia (hydroxycitric acid) has case reports of hepatotoxicity and no meaningful lactation safety data.
If your goal is to lose pregnancy weight, our coverage of fat burners for women goes into detail on what these products do and do not do, and emphasises that none of them are recommended during breastfeeding. The postpartum window is not the time for a sympathomimetic stack.
Other supplements and herbs to skip in lactation
Beyond the weight-loss category, a short list of substances are either contraindicated or warrant careful avoidance during breastfeeding: high-dose retinol vitamin A (preformed vitamin A — not beta-carotene), aloe latex (cathartic anthraquinones transfer to milk), kava (hepatotoxicity, no safety data in lactation), comfrey (pyrrolizidine alkaloid liver toxicity), ephedra and ma huang (sympathomimetic, banned in the US for this reason), licorice root at high doses (potential hypertension and electrolyte effects), and most "detox" or "cleanse" formulations of unknown composition.
A note on collagen
A common secondary question new mothers ask is whether collagen is safe during pregnancy or breastfeeding. The short version: collagen is a food protein that digests to amino acids and small peptides. There is no specific known risk in lactation, but there are also no randomised trials. The InfantRisk Center classifies the evidence as "insufficient" rather than "negative", meaning the protein itself is unlikely to be harmful but well-controlled data does not exist. For pregnant and nursing mothers who choose to use collagen, the practical guidance is to favor third-party-tested bovine over marine (mercury bioaccumulation in fish is the relevant concern), and to insist on disclosed heavy-metal testing. Our deep dive on best collagen supplements for women covers this question and the broader collagen evidence, including the "is collagen safe during pregnancy" sub-section.
What actually helps when supply feels low (and when to call an IBCLC)
Because the headline of this article is supplements, it is worth ending the active-treatment portion with the interventions that the evidence actually supports more strongly.
Mechanical first
Address feeding frequency before adding a supplement. In the first weeks postpartum, 8–12 effective feeds per 24 hours is the typical range; even after the early weeks, supply is sustained by frequent enough removal to keep FIL accumulation in check. If you are pumping, ensure flange fit is correct (a frequent and under-diagnosed cause of low pump output and pain), and consider hands-on pumping or breast compressions during the session. Power-pumping protocols, which use short pump sessions clustered to mimic cluster feeding, can up-regulate supply in pump-dependent contexts.
Hydration, sleep, calories, and prenatal continuation
Hydration past adequate does not increase supply, and chasing high water intake is unnecessary. Calorie restriction, especially aggressive postpartum diets, can suppress supply. Severe sleep deprivation modestly impacts prolactin and let-down. Continue your prenatal vitamin during lactation — folate, B12, iron, iodine, and DHA needs persist while nursing. For broader guidance, our overview of prenatal vitamins and continuation while nursing covers the relevant micronutrients. The Hollis 2015 trial showed maternal vitamin D supplementation at 6,400 IU/day can supply the nursing infant via milk, removing the need for direct infant drops — discuss this with your paediatrician [hollis2015]. For DHA, 200–300 mg/day from a prenatal omega-3 supplement during lactation is the current ACOG-aligned default.
When to call an IBCLC
Persistent perception of low supply, especially when paired with infant signs (poor weight gain, fewer than expected wet or dirty diapers, painful feeds, or maternal nipple damage), is the time to involve a lactation consultant. An IBCLC can assess latch, weigh feeds, identify mechanical issues, and help rule out underlying medical causes that no supplement can address: hypothyroidism, retained placenta, Sheehan's syndrome, polycystic ovary syndrome, insufficient glandular tissue, prior breast surgery, and the effects of hormonal contraception, among others. For ongoing recovery and broader supplementation context, see postpartum recovery supplements and the breastfeeding support category landing.
Frequently asked questions
Does fenugreek really work to increase milk supply?
The evidence is mixed and small. Some randomised trials show a milk-volume increase versus placebo at doses of about 1,800–6,000 mg per day, while pooled analyses including the Cochrane review rate the overall evidence as low quality [bumrungpert2018] [foong2020]. Some mothers respond within 24–72 hours; others do not respond at all. If you choose to try it, layer it on top of frequent effective milk removal, not in place of it, and review the contraindications below first.
How long does it take for galactagogues to work?
For fenugreek, mothers who respond typically see an effect within 24–72 hours, and the maple-syrup smell that signals systemic absorption appears within a few days. For moringa, the Philippine trials showed pumped milk volumes diverging from placebo by postpartum day 3–5 [estrella2000]. For domperidone, milk volume changes appear within 24–72 hours of starting therapy in responders [grzeskowiak2018]. None of these are instant interventions, and a one- to two-week trial is usually needed to judge response.
Is fenugreek safe while breastfeeding?
Fenugreek is classified L3 in Hale's Lactation Risk Categories — limited data, probably compatible — for most mothers, but specific groups should avoid it: those with diabetes (hypoglycaemic effect), asthma (legume cross-reactivity), chickpea or peanut allergy (documented anaphylaxis case reports), and anyone on anticoagulants such as warfarin [hale_lactrisk] [patil1997_fenugreek_anaphylaxis] [medlineplus_fenugreek]. Mothers and breastfed infants may develop a maple-syrup body odor, which is benign but should be flagged to the paediatrician so it is not confused with maple syrup urine disease.
Can I take a fat burner or weight-loss supplement while breastfeeding?
No. Weight-loss supplements typically combine stimulants (caffeine concentrates, yohimbine, synephrine), green tea extract at hepatotoxic concentrations, CLA, and garcinia cambogia — each with documented or plausible safety concerns for nursing mothers or their infants. EFSA flagged green tea catechin hepatotoxicity at intakes around 800 mg EGCG per day [efsa_egcg2018]. LactMed advises against yohimbine during breastfeeding [lactmed_yohimbine]. Our fat burners for women article covers the broader category and reinforces that none of these are appropriate during lactation.
Is collagen safe during pregnancy or breastfeeding?
There are no randomised controlled trials of collagen in pregnancy or lactation, but collagen is a food protein that digests to amino acids and small peptides, with no specific known risk. The honest classification is "insufficient evidence, no documented harm". Favor bovine over marine collagen during pregnancy and nursing because of mercury bioaccumulation in fish, and use only third-party-tested products. Our best collagen supplements for women deep dive covers this in more detail.
What is the best natural supplement to increase milk supply?
If pressed to name one, moringa has the most consistent trial direction among herbal options, primarily from two Philippine RCTs in mothers of preterm infants [estrella2000] [espinosa_kuo2005]. The effect may be partly nutritional rather than purely pharmacological. Fenugreek is more familiar and more commonly stocked but has more contraindications and weaker pooled evidence. The most important "natural" intervention — frequent effective milk removal, latch correction, IBCLC support — is not a supplement at all.
Should I take lactation tea or lactation cookies?
These products typically deliver sub-therapeutic doses of fenugreek and blessed thistle alongside fennel, anise, and (in cookies) oats and brewer's yeast. They are not unsafe at usual consumption for most mothers, but their pharmacological effect is small. Treat them as ritual, hydration, and modest calorie support rather than a pharmacologically meaningful galactagogue. If they feel reassuring and you tolerate them, there is no reason to avoid them.
Is domperidone safe for increasing milk supply?
Domperidone is the galactagogue with the strongest evidence for increasing milk volume — about 85 mL per day versus placebo in pooled trials [grzeskowiak2018]. It is also the one with the most serious safety profile: the FDA issued a 2004 warning against its use for lactation citing QT-prolongation and cardiac arrhythmia risk, and it is not FDA-approved in the United States [fda_domperidone_2004]. It is available by prescription in the EU, UK, Australia, and Canada, with Health Canada advising dose limits at or below 30 mg per day. The decision to use it belongs to a physician who can evaluate your cardiac, electrolyte, and medication context — this is not a self-administered supplement.
The bottom line
Most supplements to increase milk supply work less reliably than their marketing suggests. The Cochrane review concluded the evidence base is too low-quality to support routine recommendation, and ABM Clinical Protocol #9 places skin-to-skin contact, frequent effective milk removal, and IBCLC support ahead of any pill or tea [foong2020] [abm_protocol9]. Among the options that do have trial data, moringa has the most consistent direction of effect, fenugreek has mixed evidence and a real list of contraindications (diabetes, asthma, anticoagulants, chickpea or peanut allergy, the maple-syrup smell flag), and domperidone has the strongest evidence but is a prescription pharmaceutical with QT-prolongation concerns and is not FDA-approved in the US. The single most useful thing this article can do is steer you away from one specific mistake: do not take weight-loss supplements or fat burners while nursing. The safety profiles are not aligned with lactation, and there is no version of "lose pregnancy weight faster" that is worth the trade-off. When in doubt, the call is to your IBCLC and your physician, in that order.
